MAZZEO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 1.554
EU - Europa 1.104
AS - Asia 363
OC - Oceania 21
AF - Africa 2
SA - Sud America 2
Totale 3.046
Nazione #
US - Stati Uniti d'America 1.544
RU - Federazione Russa 645
IT - Italia 161
IE - Irlanda 109
SG - Singapore 105
SE - Svezia 99
HK - Hong Kong 90
CN - Cina 78
DE - Germania 32
JO - Giordania 30
IN - India 25
ID - Indonesia 22
AU - Australia 21
FI - Finlandia 15
GB - Regno Unito 12
KR - Corea 10
CA - Canada 8
CH - Svizzera 6
NL - Olanda 5
ES - Italia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
BR - Brasile 2
CI - Costa d'Avorio 2
DK - Danimarca 2
FR - Francia 2
PA - Panama 2
BG - Bulgaria 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
PL - Polonia 1
PT - Portogallo 1
UA - Ucraina 1
VN - Vietnam 1
Totale 3.046
Città #
Santa Clara 693
Chandler 133
Dublin 109
Fairfield 85
Singapore 84
Ashburn 69
Hong Kong 69
Seattle 53
Moscow 45
Woodbridge 39
Houston 37
Altamura 31
Lawrence 30
Florence 29
Cambridge 28
Wilmington 26
Bremen 25
Jakarta 22
Shanghai 20
Melbourne 19
Mumbai 19
Dallas 18
Buffalo 16
Princeton 16
Helsinki 13
New York 12
Kent 10
Beijing 9
Boston 9
Los Angeles 9
Medford 9
Toronto 8
Ann Arbor 7
Seoul 7
San Diego 6
West Jordan 6
Yubileyny 6
Dearborn 5
Pune 5
Boardman 4
London 4
Naples 4
Zurich 4
Bolzano 3
Brussels 3
Como 3
Duncan 3
Kunming 3
L’Aquila 3
Milan 3
Palermo 3
Abidjan 2
Arezzo 2
Bern 2
Canberra 2
Catania 2
Colle di Val d'Elsa 2
Copenhagen 2
Falls Church 2
Genoa 2
Guangzhou 2
Hillsboro 2
Lappeenranta 2
Manchester 2
Matelica 2
Monza 2
Norwalk 2
Panama City 2
Pisa 2
Poggibonsi 2
Prague 2
Sant'Agata di Militello 2
Suwon 2
Turin 2
Villasanta 2
Andover 1
Athens 1
Bagno A Ripoli 1
Barcelona 1
Bitola 1
Bologna 1
Brentford 1
Böblingen 1
Campi Bisenzio 1
Chennai 1
Chongqing 1
Dalian 1
Fiesole 1
Fontebuona 1
Frankfurt am Main 1
Fuzhou 1
Grottaferrata 1
Harbin 1
Hebei 1
Hounslow 1
Kilburn 1
Kumamoto 1
Lisbon 1
Loudi 1
Lucca 1
Totale 1.949
Nome #
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 144
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 142
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 134
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 127
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 121
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 116
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 101
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 99
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 99
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 95
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 94
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 91
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 89
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 85
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 82
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 80
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 78
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 77
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 73
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 73
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 73
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 72
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 72
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 69
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 66
Intermediate alleles of HTT: A new pathway in longevity 64
null 63
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 61
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 57
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 56
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 55
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 53
Depressive Symptoms Moderate the Association Between Functional Level at Admission to Intensive Post-Stroke Rehabilitation and Effectiveness of the Intervention 53
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 51
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 51
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 50
Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings 48
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 29
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 22
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 20
Totale 3.085
Categoria #
all - tutte 12.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 0 27 21 20 17 12 8
2020/2021118 11 6 2 20 9 5 4 9 24 8 12 8
2021/2022105 4 0 6 3 2 8 0 13 7 10 19 33
2022/2023587 58 117 42 44 40 92 69 28 80 2 11 4
2023/2024331 5 25 28 12 26 38 26 73 11 42 25 20
2024/20251.722 73 223 132 379 534 369 12 0 0 0 0 0
Totale 3.085